KELCI COUCH: Open Payments
NPI 1326694191 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 27 payments from 8 companies in 2025. Trend: 2023 $436 · 2024 $970 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $458 |
| Lilly USA, LLC | 4 | $75 |
| ABBVIE INC. | 3 | $68 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Dexcom, Inc. | 2 | $34 |
| Madrigal Pharmaceuticals | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Wegovy, LINZESS, MOUNJARO, JOURNAVX, Dexcom G6 Transmitter, REZDIFFRA, VOQUEZNA, Ozempic.
Industry payments across MO — which companies pay providers there.
